Ryan Crowe | Vice President, Investor Relations |
Dave Marek | Chief Executive Officer |
Lauren Merendino | Chief Commercial Officer |
Uneek Mehra | Chief Financial and Business Officer |
Juan Camilo Arjona | Chief Medical Officer |
Brian Skorney | Baird |
Phil Nadeau | Cowen |
Roanna Ruiz | SVB Leerink |
Gavin Clark-Gartner | Evercore ISI |
Madhu Kumar | Goldman Sachs |
Eric Joseph | JPMorgan |
Good day everyone and welcome to Myovant Sciences' Second Quarter of Fiscal Year 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, Vice President of Investor Relations at Myovant. Please go ahead.
Thank you, operator.